X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9%
Thu, 9 May

ALEMBIC PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m8,53310,1829,270-9.0%8.6%
Other incomeRs m63534-4.3%426.6%
TurnoverRs m8,54010,2179,303-8.9%8.9%
ExpensesRs m6,8017,7597,489-3.5%10.1%
Gross profitRs m1,7302,4221,783-26.4%3.1%
DepreciationRs m3162913003.1%-5.1%
InterestRs m136051-14.6%279.1%
Profit before taxRs m1,4082,1081,467-30.4%4.2%
TaxRs m385400149-62.8%-61.3%
Profit after taxRs m1,0221,7081,318-22.8%28.9%
Gross profit margin%20.323.819.2
Effective tax rate%27.419.010.2
Net profit margin%12.016.714.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 8.6% on a year-on-year (YoY) basis. The expenses were up by 10.1% YoY during the same period.
  • The company's operating profit increased by 3.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 19.2% in 4QFY19 as against 20.3% in 4QFY18.
  • Depreciation charges declined by 5.1% and finance costs increased by 279.1% YoY, respectively.
  • Other income increased by 426.6% YoY during the quarter.
  • Net profit for the quarter increased by 28.9% YoY. Net profit margins during the quarter increased from 12.0% in 4QFY18 to 14.2% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 9.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 3.5% QoQ during the same period.
  • The company's operating profit declined by 26.4% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 19.2% in 4QFY19 as against 23.8% in 3QFY18.
  • Net profit for the quarter declined by 22.8% QoQ, while net profit margins declined from 16.7% in 3QFY18 to 14.2% in 4QFY19.

To see how ALEMBIC PHARMA has performed over the last eight quarters, please visit here.

ALEMBIC PHARMA Share Price Performance

Over the last one year, ALEMBIC PHARMA share price has moved up from Rs 500.2 to Rs 540.5, registering a Gain of Rs 40.4 or around 8.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,836.6 (down 0.1%). Over the last one year it has moved up from 13,682.5 to 13,836.6, a gain of 154 points (up 1.1%).

Overall, the S&P BSE SENSEX is up 6.9% over the year.

Current Valuations

At the current price of Rs 540.5, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 17.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.6 times.

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9%". Click here!

  

Related Views on News

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 42.6% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, ALEMBIC PHARMA has posted a net profit of Rs 904 m (up 42.6% YoY). Sales on the other hand came in at Rs 9 bn (up 33.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jul 19, 2019 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - TEVA PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS